# Gene Therapy for SLC6A1 Neurodevelopmental Disorder

> **NCT07173153** · PHASE1,PHASE2 · ENROLLING_BY_INVITATION · sponsor: **Emily de los Reyes** · enrollment: 1 (estimated)

## Conditions studied

- SLC6A1

## Interventions

- **BIOLOGICAL:** AAV9.SLC6A1 Gene Therapy

## Key facts

- **NCT ID:** NCT07173153
- **Lead sponsor:** Emily de los Reyes
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-08-25
- **Primary completion:** 2028-08-25
- **Final completion:** 2030-08-25
- **Target enrollment:** 1 (ESTIMATED)
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07173153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07173153, "Gene Therapy for SLC6A1 Neurodevelopmental Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07173153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*